In focus · trending topic

phase 3 trial

2 stories · following the connections

Adamas Announces First Patient Enrolled in Phase 3 Trial of ADS-5102 in Multiple Sclerosis Patients with Walking Impairment

By Nasdaq OMXApr 3, 2018, 1:02 PM UTC

Vital Therapies Provides Corporate Update

By Nasdaq OMXJan 9, 2017, 1:01 PM UTC